tiprankstipranks
CymaBay Therapeutics (GB:0I5P)
LSE:0I5P

CymaBay Therapeutics (0I5P) Stock Investors

0 Followers
Based on 723,149 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0I5P
On average, investors allocate 6.38% of their portfolios to GB:0I5P
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0I5P

1.8%
Last 7
Days
8.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0I5P, out of 723,149 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0I5P Investor Activity

No data currently available
Based on the activity of 13,604 investors who made their portfolios public
The table shows changes in 0I5P in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0I5P Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Raytheon Technologies
4.10%
-0.30%
-0.77%
127.03B
Industrials
DraftKings
7.22%
+0.86%
+1.66%
40.91B
Consumer Cyclical
ChargePoint Holdings
3.95%
-1.04%
-3.27%
727.37M
Consumer Cyclical
Micron
5.59%
+10.90%
+26.10%
122.04B
Technology
Merck & Company
4.04%
+0.19%
+0.58%
313.67B
Healthcare
Coherus Biosciences
2.69%
-0.54%
-3.68%
259.48M
Healthcare
Assertio Therapeutics
2.70%
-1.15%
-4.74%
98.80M
Healthcare
Delta Air Lines
5.43%
+0.48%
+0.31%
29.33B
Industrials
Marvell
4.73%
+2.09%
+11.09%
57.62B
Technology
Riot Platforms
4.98%
+0.99%
+6.18%
2.89B
Financial
Based on the activity of 723,149 active portfolios
Open your Smart Portfolio

0I5P Investor Analysis

GB:0I5P investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.5%
of GB:0I5P holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
GB:0I5P investors between 35–55

Between 35–55

3.3%
Last 30 days
Holdings Change
49.1%
of GB:0I5P holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
GB:0I5P investors over 55

Over 55

17.7%
Last 30 days
Holdings Change
35.4%
of GB:0I5P holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of GB:0I5P stock investors
See who invests in 0I5P according to age group and performance.

FAQ

How many retail Investors hold GB:0I5P?
<0.1% of TipRanks' retail investors hold GB:0I5P in their portfolios.
    What is GB:0I5P Investor Sentiment?
    GB:0I5P’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0I5P in the last 7 days?
      ▼ 1.8% of TipRanks' retail investors changed their holding of GB:0I5P in the last 7 days.
        What percentage of retail investors changed their holding of GB:0I5P in the last 30 days?
        ▼ 8.7% of TipRanks' retail investors changed their holding of GB:0I5P in the last 30 days.
          What is the average age of retail investors who hold GB:0I5P?
          The average age of GB:0I5P Holders is between 35–55.
            What other stocks have GB:0I5P investors also bought?
            GB:0I5P Investors also bought RTX, DKNG, CHPT, MU, MRK, CHRS, ASRT, DAL, MRVL, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              AZNAstraZeneca
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis